Viral hepatitis commonly was a hepatitis B
and hepatitis C. In the United States it is probably more common with hepatitis C and
we have a lot of achievement in terms of the treatment for the hepatitis C. So a lot of
exciting and very effective medications have come out. It's really promising for the people
for people with hepatitis C. So the hepatitis B is a little bit different. This is a chronic
condition. It's more common in the Asian population. However because of the immigration we do see
a lot of hepatitis B infection in the clinic as well. And this patient needs the the cure
is slightly different than hepatitis C because of the nature of the disease. So I feel like
the viral the hepatitis is quite interesting in terms of their management. Chronic hepatitis
B depends on this varies because of it's a it's it's a DNA virus so it's very difficult
to use a medication to clear this virus.
That's why it's very hard, not like hepatitis C.
It's not it's very hard to cure hepatitis B. Hepatitis B management is different based
on the viral replication based on different phase of the hepatitis B infection. And also
depends on the patient's other conditions such as coinfection with hepatitis C and or
with HIV. And the other thing for the hepatitis B is interesting is even if people have immunity
or they have previously had the hepatitis B infection, when they become sick such as
when they are a during the have chemotherapy for other cancer so the hepatitis B can be
reactivated and people can be very sick from that. We do have treatment for the hepatitis
B and the other thing is for the hepatitis B the the people don't usually, if it's a
chronic infection, people don't usually have much symptoms. So what we typically do is
to keep an eye close eye on the liver is because hepatitis B can have have increased risk for
cancer even without progressing to cirrhosis.
So this is one big part for compared to the
hepatitis C. So this routine follow up and close monitor is very important for the hepatitis
B management..
